Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

3 Huge Healthcare Trends Can Fatten Your Portfolio

Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities

CERS CRIS CGEN CPHD – 4 Fab Biotech Stocks on the Fast Track

Biotech stocks are a compelling sector, and we've had great success in our picks. Here's an update on my four favorites in the sector

Regeneron Stock Is Winning on Two Fronts

Regeneron stock has continually rewarded the medium- and longer-term bulls, and following REGN earnings Tuesday, the good times are primed to keep rolling.

Generate Income on a Plummeting Pharma Stock

QCOR is down a whopping 15% on the news that the Fed is investigating them again. Use the news to generate income with puts.

5 Pet Stocks Fetching Big Returns

Pet stocks have been on a wild run this year, with some biotechs at least doubling in value. Here are the five hottest players in the space so far in 2013.

4 Red-Hot Niche Healthcare Stocks

Here's proof that building a better mousetrap can sometimes make better fiscal sense ... for investors of healthcare stocks.

Q3 Earnings Roundup for Pharmaceutical Stocks

None of the market's major pharmaceutical stocks are in the same boat. Here's the main thing investors need to know about each.

The 3 Best Biotech ETF Investments

A biotech ETF is the best way to bet on booming biotech stocks ... and these three funds are a few of the best ETF options out there.

New Drug Could Cut ‘Bad’ Cholesterol Nearly in Half

Late stage trials of Alirocumab, an anti-cholesterol drug from Regeneron and Sanofi, showed promising results.

Don’t Bet Against Biotech in 2013 … or Ever

Betting against biotech is usually a dangerous game for retail investors -- add leverage and you're entering Crazytown.

Flu Season Is Coming — And These Companies Are Ready

Flu season is slowly getting started -- bad news for us, but welcome news for companies that benefit from flu sufferers' ills. Here's a look at some of them.

Biotech Blowout: 3 Stocks Taking a Hit

The risky side of biotech stocks reared its ugly head in the past couple of days, sending three stocks to the mat in the wake of bad news.

Should I Buy GlaxoSmithKline (GSK)? 3 Pros, 3 Cons

GlaxoSmithKline is seeking approval for the world's first malaria vaccine, but high debt and low growth mean investors should think twice before buying.

Look to Supplier Stocks for an Obamacare Trade

Wall Street hasn't paid much attention to Questcor (QCOR), a drug company with patients that could be moving to Medicaid in droves.

Roche’s Breast Cancer Drug Approval Is Just the Beginning

It might have been dismissed as irrelevant by most investors, but Roche and its Perjeta could reshape the breast cancer drug landscape.

Obamacare Won’t Deliver — Sell Hospital and Managed Care Stocks, STAT!

By Jeff Reeves -- Obamacare might never deliver on the hopes of perpetually higher healthcare stock prices, and many bid-up companies could end up disappointing shareholders.

Medical Device Companies Still Have Upside, New Tax or Not

By Dan Burrows -- A sales tax on medical devices under Obamacare has spooked investors in medical device companies, but behemoths like Medtronic and Stryker will shrug it off.

2 Top Healthcare Stock Picks for Obamacare

By Louis Navellier -- The Affordable Care Act (aka Obamacare) will improve the prospects of these two healthcare stocks.

5 Stocks Leading the Generic Drug Charge

As pervasive as generic drug usage has already become, experts say there's still lots of room to grow. These companies are leading that charge.